Sunday, November 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· June 30, 2026

DeepSeek's DSpark Just Made Nvidia's Most Important New Bet Harder to Close

View original at nasdaq.com
DeepSeek's DSpark Just Made Nvidia's Most Important New Bet Harder to Close Key Points Nvidia's GPU business is not in question. What is in question is the incremental hardware layer Nvidia is now trying to sell on top of it…
Opening lines of the source · short snapshot: read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Confirmed more than $1 trillion in combined Blackwell and Rubin purchase orders through 2027.

    60% confidence
  • DeepSeek-V4-Pro needs roughly 10% of the memory that V3.2 required for million-token conversations.

    60% confidence
  • The Groq 3 LPX and Vera Rubin NVL72 combination delivers up to 35 times higher inference throughput per megawatt for trillion-parameter models.

    60% confidence
  • Stock Advisor's total average return is 902%, a market-crushing outperformance compared to 207% for the S&P 500.

    60% confidence
  • Throughput at a fixed service level improved 51%.

    60% confidence
  • The AWS-Cerebras disaggregated inference solution delivers inference an order of magnitude faster than existing GPU-only solutions.

    60% confidence
  • Full-year fiscal 2027 Data Center revenue consensus sits near $343 billion.

    60% confidence
  • MLA compression reduced KV cache requirements by over 90% across DeepSeek's model generations.

    60% confidence
  • Per-user generation speed improved 60% to 85% on DeepSeek-V4-Flash and 57% to 78% on V4-Pro over the prior baseline.

    60% confidence
  • Consensus Data Center gross margin for fiscal 2027 is projected at 76.3%, slightly below fiscal 2024 and 2025 levels.

    60% confidence

Data points we hold from this source

Stock Advisor · market share902 percent_total_average_return
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Conflicts between sources are checked by an editor before we publish them here.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,959
facts traced to their source, and we flag the ones that don't hold up.
101 entities tracked4,959 facts checked against source5,585 source documents archived
Query this data → isubstrate.com

Working data, not the finished story. This is what our AI has read and extracted from source documents so far. How we source

DeepSeek's DSpark Just Made Nvidia's Most Important New Bet Harder to Close: Source | Via News | finance.via.news